NEW! Cost Savings Calculator

See how much you could save by prescribing Trustsaver® products

Laxido® Orange

(macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride)

Up to 49% savings with Laxido® Orange vs MOVICOL®1

Contact us today
Laxido® Orange

At-a-glance

  • Indicated for chronic constipation and faecal impaction in those aged 12 years and over2

  • Effective, market-leading osmotic laxative2,3

  • Contains macrogol 3350, plus electrolytes2

  • Proven, well tolerated active ingredients2

  • Simple, easy-to-mix

  • Orange flavoured2

Allergy & Dietary Information

Vegan

Vegan

Gluten Free

Gluten Free

Lactose Free

Lactose Free

Nut Free

Nut Free

Active ingredients like for like with MOVICOL®2,4

Make significant drug acquisition cost savings vs. MOVICOL® by prescribing Laxido® Orange by brand1

Get personalised savings
Assumptions and Calculations References Prescribing Information
Assumptions and Calculations

  • Percentage savings with Laxido® Orange are calculated based on MIMS list prices.1

  • The NHS list price of Laxido® Orange is £2.85 per 20 sachet pack and £4.10 per 30 sachet pack, and the NHS list price of MOVICOL® is £5.41 per 20 sachet pack, £8.11 per 30 sachet pack and £13.49 per 50 sachet pack.1

References

  1. MIMS Online. Accessed August 2020.

  2. Laxido® Orange. Summary of Product Characteristics. November 2018.

  3. Data on File I. Galen Limited.

  4. MOVICOL® 13.8g sachet, powder for oral solution. Summary of Product Characteristics April 2019.

Prescribing Information

MOVICOL® is a registered trademark of the Norgine® group of companies.

Request personalised potential savings

Provide a few quick details and we'll get back to you with the savings your organisation could make with Trustsaver®

Galen will not share your email address with any third parties. By requesting information you are under no obligation to meet with a Galen representative. By submitting your information you acknowledge that you have read the Galen privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to customer.services@galen-pharma.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.

By using this website, you agree to the use of cookies as described in our Privacy Policy.

Accept

Designed to help prescribing budgets go further

I am a Healthcare Professional
I am a Patient
The Trustsaver® portfolio of products includes:
  • Dermipar® Ointment (ingredients include white soft paraffin, liquid paraffin, cetomacrogol emulsifying wax)
  • ExoCream® (ingredients include white soft paraffin 14.5% w/w, liquid paraffin 12.6% w/w and anhydrous lanolin 1.0% w/w)
  • Laxido® Orange (macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride)
  • Laxido® Paediatric Plain (macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride)
  • Miclaro™ Oat Cream (ingredients include avena sativa kernel flour 1% w/w)
  • Miclaro™ Oat Lotion (ingredients include avena sativa kernel flour 1% w/w)
  • MyriBase™ Emollient Shower Gel (ingredients include isopropyl myristate 15% w/w and liquid paraffin 15% w/w)
  • MyriBase™ Gel (ingredients include isopropyl myristate 15% w/w and liquid paraffin 15% w/w)
  • Rapilose® Gel (glucose gel 40% w/w)
  • Salivix® Plus (ingredients include malic acid and sodium fluoride)
  • Salivix® Spray (ingredients include malic acid, xylitol and sodium fluoride)
  • Thorens® 10,000 I.U./ml oral drops, solution (colecalciferol)
  • Thorens® 25,000 I.U./2.5ml oral solution (colecalciferol)
  • Zemtard® XL (diltiazem hydrochloride)

Patient Information

Galen Limited is a privately-owned pharmaceutical sales and marketing company established in 1968. By combining innovation in product development with competitive pricing, Galen aims to work in partnership with healthcare professionals and patients, a major factor in the company's success to date. If you would like to find out more about Galen, its products or information on the disease areas we cover, please visit www.galen-pharma.com.